NCT05359861 2026-03-18
Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2 Completed
Coherus Oncology, Inc.
St. Jude Children's Research Hospital
Hoffmann-La Roche
Lokon Pharma AB